Stockreport

Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025

Aditxt, Inc.  (ADTX) 
PDF Endometriosis Affects Approximately 190 Million Women WorldwideNon-invasive MET™ Diagnostic Test for Endometriosis Leverages Novel Biomarker: A Specific Deletion in Mito [Read more]